Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study

Abstract

Younger patients, especially those with vertebral localization have the best outcome when treated with moderate-dose RT. Progression to MM remains the main problem. Further investigation should focus on adjuvant chemotherapy and/or novel therapeutic agents.